博迅生物
(836504)
| 流通市值：1.95亿 | | | 总市值：6.78亿 |
| 流通股本：1248.51万 | | | 总股本：4333.31万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 40,513,208.51 | 107,991,468.99 | 87,982,573.25 | 62,885,377.28 |
| 应收票据及应收账款 | 23,528,922.47 | 15,461,132.59 | 33,784,365.1 | 34,764,408.23 |
| 其中：应收票据 | 6,002,486.57 | 12,015,393.29 | 7,158,653.63 | 4,112,219.75 |
| 应收账款 | 17,526,435.9 | 3,445,739.3 | 26,625,711.47 | 30,652,188.48 |
| 应收款项融资 | 648,971.01 | 3,746,385.83 | 1,193,049.68 | 1,015,171.39 |
| 预付款项 | 2,181,055.29 | 1,869,666.7 | 1,768,721.63 | 3,557,824.3 |
| 其他应收款合计 | 232,829.97 | 138,167.17 | 191,829.26 | 418,545.39 |
| 存货 | 34,313,741.6 | 31,373,374.5 | 32,516,170.04 | 32,739,430.4 |
| 一年内到期的非流动资产 | 1,200,335.35 | 1,200,335.35 | 485,907.04 | 1,200,335.35 |
| 其他流动资产 | 2,211,031.87 | 31,145,077.25 | 30,930,392.94 | 590,922.53 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 184,970,178.15 | 192,925,608.38 | 195,359,962.74 | 137,172,014.88 |
| 非流动资产: | | | | |
| 长期应收款 | 16,272,497.02 | 16,116,597.93 | 17,936,088.75 | 17,037,529.64 |
| 固定资产 | 19,020,593.23 | 19,514,000.24 | 20,001,168.45 | 20,473,314.63 |
| 在建工程 | 571,649.1 | 162,567.55 | - | - |
| 使用权资产 | 5,637,418 | 3,637,418.69 | 3,871,842.78 | 4,106,267.01 |
| 无形资产 | 9,647,598.48 | 9,733,336.19 | 9,700,135.85 | 9,798,085.94 |
| 长期待摊费用 | 662,912.79 | 749,847.75 | 836,782.68 | 923,717.61 |
| 递延所得税资产 | 4,097,843.68 | 3,962,435.37 | 1,675,544.2 | 1,645,522.21 |
| 其他非流动资产 | 20,510,000 | 20,373,500 | 20,235,500 | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 76,420,512.3 | 74,249,703.72 | 74,257,062.71 | 53,984,437.04 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 261,390,690.45 | 267,175,312.1 | 269,617,025.45 | 191,156,451.92 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 10,000,000 | 1,000,000 | 1,000,000 |
| 应付票据及应付账款 | 18,469,640.74 | 19,561,084.6 | 18,114,784.46 | 17,476,232.89 |
| 应付账款 | 18,469,640.74 | 19,561,084.6 | 18,114,784.46 | 17,476,232.89 |
| 合同负债 | 1,156,889.2 | 1,018,634.07 | 759,028.57 | 1,097,057.15 |
| 应付职工薪酬 | 2,277,227.86 | 3,965,717.51 | 3,060,221.64 | 2,799,600.07 |
| 应交税费 | 3,364,685.86 | 5,455,567.7 | 5,117,170.66 | 4,946,540.72 |
| 其他应付款合计 | 3,379,491.88 | 6,576,944.16 | 4,215,663.83 | 3,616,849.44 |
| 一年内到期的非流动负债 | 2,003,228.67 | 1,200,335.35 | 807,661.52 | 1,210,822.77 |
| 其他流动负债 | 5,374,565.26 | 7,534,179.07 | 5,050,131.87 | 3,680,534.01 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 46,025,729.47 | 55,312,462.46 | 38,124,662.55 | 35,827,637.05 |
| 非流动负债: | | | | |
| 租赁负债 | 19,452,235.59 | 17,385,940.86 | 17,937,226.32 | 17,757,940.86 |
| 递延收益 | 1,383,250 | 1,438,000 | 1,492,750 | 1,547,500 |
| 递延所得税负债 | 352,385.03 | 24,516.29 | 52,823.38 | 81,130.48 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 21,187,870.62 | 18,848,457.15 | 19,482,799.7 | 19,386,571.34 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 67,213,600.09 | 74,160,919.61 | 57,607,462.25 | 55,214,208.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 43,333,100 | 43,333,100 | 43,333,100 | 35,000,000 |
| 资本公积 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 | 51,135,988.52 |
| 盈余公积 | 16,737,149.39 | 16,737,149.39 | 13,866,252.82 | 13,866,252.82 |
| 未分配利润 | 19,516,709.31 | 18,354,011.44 | 40,220,078.72 | 35,940,002.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 194,177,090.36 | 193,014,392.49 | 212,009,563.2 | 135,942,243.53 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 194,177,090.36 | 193,014,392.49 | 212,009,563.2 | 135,942,243.53 |
| 负债和股东权益合计 | 261,390,690.45 | 267,175,312.1 | 269,617,025.45 | 191,156,451.92 |
| 公告日期 | 2024-04-26 | 2024-03-15 | 2023-10-30 | 2023-07-31 |
| 审计意见(境内) | | 标准无保留意见 | | |